Impact of Vitamin D3 Dietary Supplement Matrix on Clinical Response
Michael L. Traub, John S. Finnell, Anup Bhandiwad, Erica Oberg, Lena Suhaila, and Ryan Bradley
JCEM DOI: http://dx.doi.org/10.1210/jc.2013-3162, Published Online: March 31, 2014
10,000 IU given once in 3 forms
See also VitaminDWiki
- Vitamin D bioavailability: State of the art – Oct 2014
- Vitamin D – water-soluble is far more absorbable than fat-soluble – Nov 2016
- Low Cost vitamin D - including liquid and bulk
- All items in category Forms of Vitamin D
Download the PDF from VitaminDWiki
Context: As a result of research suggesting increased health risk with low serum 25-hydroxycholecalciferol (25(OH)D), healthcare providers are measuring it frequently. Providers and patients are faced with treatment choices when low status is identified.
Objective: To compare the safety and efficacy of three vitamin D3 dietary supplements with different delivery matrices.
Design & Setting: 12-week, parallel group, single-masked, clinical trial conducted in Seattle, WA and Kailua Kona, HI.
Participants & Intervention: 66 healthy adults with (25(OH)D) < 33 ng/ml were randomly assigned to take one of three D3 supplements, i.e., a chewable tablet (TAB), an oil-based drop (DROP) or an encapsulated powder (CAP), at a label-claimed dose of 10,000 IU/day. Actual D3 content was assessed by a third-party, and the results adjusted based on the actual D3 content administered.
Main Outcome Measures:
mean change in 25(OH)D/mcg D3 administered; difference in the proportion of D3 insufficient participants (i.e., 25(OH)D ≤30ng/ml) reaching sufficiency (i.e., 25(OH)D ≥30ng/ml); and mean change in serum 1, 25-dihydroxycholecalciferol.
In two of the three products tested, the measured vitamin D3 content varied considerably from the label-claimed dose. Differences in 25(OH)D/mcg D3 administered were significantly different between groups (p=0.04; n=55). Pairwise comparisons demonstrated DROP resulted in a greater increase than TAB (p<0.05) but not than CAP. TAB was not different from CAP.
The proportions reaching sufficiency were:
- 100% (TAB and CAP) and
- 80% (DROP) (p=0.03 between groups, n=55).
1, 25-dihydroxycholecalciferol did not change significantly in any group.
Conclusions: Oil-emulsified vitamin D3 supplements resulted in a greater mean change in serum 25(OH)D concentration, but fewer patients reaching vitamin D sufficiency, than chewable or encapsulated supplements.
Affiliations: Lokahi Health Center, Kailua Kona, HI, USA; AOMA Graduate School of Integrative Medicine; Austin, TX, USA; Wayne State University, Detroit, MI, USA; Pacific Pearl Center for Health and Healing; La Jolla, CA, USA; Cancer Treatment Centers of America Western Regional Medical Center; Phoenix, AZ, USA; Bastyr University Research Institute; San Diego, CA, USAThis page was renamed Jan 2019. There have actually been
11297 visitors to this page since it was originally madeOil-based Vitamin D3 has the worst bioavailability – April 2014 5108 visitors, last modified 02 Jan, 2019,This page is in the following categories (# of items in each category)
ID Name Comment Uploaded Size Downloads 7349 Matrix 25.jpg admin 17 Nov, 2016 18:22 16.59 Kb 2704 7348 Vitamin D3 Dietary Supplement Matrix.pdf admin 17 Nov, 2016 18:13 595.67 Kb 1325